Having new molecules will give doctors more options to select a drug that caters precisely to individual patients needs. CORRECTION This story was updated on April 10, 2026, to correctly describe the intended dosing of the injectable amylin-mimicking weight-loss drug being developed by Alveus Therapeutics
Several legitimate concerns deserve attention, and ignoring them could mean trading one set of problems for another
Its shown to effectively bind to anti-aging targets and has antioxidant activity, helping to smooth wrinkles and reduce expression lines, especially on the forehead and around the mouth
NS was used instead of GSH in the control group
Duggan C, Wang C-Y, Neuhouser ML, Xiao L, Smith AW, Reding KW, et al